10 employees
Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
2013
$20M
from 3 investors over 3 rounds
Lyric Pharmaceuticals Inc. raised $20M on February 23, 2015
Investors: RiverVest Venture Partners, - and Aperture Venture Partners